Fluoroquinolone-Induced Rotator Cuff Tendinopathy: A Case Report

Hussam Alkaissi¹, Srinivas Kolla², Cameron Page¹, Latif Salam¹, Moro O. Salifu¹ and Isabel M. McFarlane^1,

¹Department of Internal Medicine, State University of New York, Downstate Health Sciences University, Brooklyn, NY 11203, USA

²Department of Radiology, State University of New York, Downstate Health Sciences University, Brooklyn, NY 11203, USA

Cite this paper

Hussam Alkaissi, Srinivas Kolla, Cameron Page, Latif Salam, Moro O. Salifu and Isabel M. McFarlane. Fluoroquinolone-Induced Rotator Cuff Tendinopathy: A Case Report. American Journal of Medical Case Reports. 2021; 9(2):122-124. doi: 10.12691/AJMCR-9-2-6

Abstract

Fluoroquinolones are antimicrobial agents that inhibit bacterial DNA synthesis by binding to DNA gyrase and DNA topoisomerase IV. Fluoroquinolones have also been associated with the development of tendinopathy, tendon rupture, and arthropathy. The postulated mechanisms for quinolone-associated tendinopathy are alteration of the tendon extracellular matrix, impairment of tenocyte proliferation, and enhanced apoptosis due to the quinolone cation chelation properties. We present a case of a man who developed multiple tears of the rotator cuff after exposure to levofloxacin. Although marketed quinolones are well tolerated, adverse events involving gastrointestinal, cardiovascular, neurological, and tendinopathy and at-risk patient populations should be kept in mind by clinicians.

Keywords

fluoroquinolone, tendinopathy, rotator cuff

Copyright

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]	Oliphant CM, Green GM. Quinolones: a comprehensive review. Am Fam Physician. 2002 Feb 1; 65(3): 455-64. PMID: 11858629.
[2]	Bailey RR, Kirk JA, Peddie BA. Norfloxacin-induced rheumatic disease. N Z Med J. 1983 Jul 27; 96(736): 590. PMID: 6223241.
[3]	Khaliq Y, Zhanel GG. Fluoroquinolone-associated tendinopathy: a critical review of the literature. Clin Infect Dis. 2003 Jun 1; 36(11): 1404-10. Epub 2003 May 20. PMID: 12766835.
[4]	Araujo Eyer-Silva, Walter de, Henrique de Barros Pinto Netto, Jorge Francisco da Cunha Pinto, Fernando Raphael de Almeida Ferry, and Rogério Neves-Motta. “Severe Shoulder Tendinopathy Associated with Levofloxacin.” The Brazilian Journal of Infectious Diseases 16, no. 4 (July 1, 2012): 393-95.
[5]	Childs, Sharon G. Pathogenesis of Tendon Rupture Secondary to Fluoroquinolone Therapy, Orthopaedic Nursing: May-June 2007 - Volume 26 - Issue 3 - p 175-182.
[6]	Lewis T, Cook J. Fluoroquinolones and tendinopathy: a guide for athletes and sports clinicians and a systematic review of the literature. J Athl Train. 2014; 49(3): 422-427.
[7]	Wilton LV, Pearce GL, Mann RD. A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies. Br J Clin Pharmacol. 1996 Apr; 41(4): 277-84.
[8]	van der Linden PD, Sturkenboom MC, Herings RM, Leufkens HG, Stricker BH. Fluoroquinolones and risk of Achilles tendon disorders: case-control study. BMJ. 2002; 324(7349): 1306-1307.
[9]	Nessrine A, Zahra AF, Taoufik H. Musculoskeletal involvement in sarcoidosis. J Bras Pneumol. 2014; 40(2): 175-182.
[10]	Katie Bechman, Dimitrios Christidis, Sarah Walsh, Surinder S Birring, James Galloway, A review of the musculoskeletal manifestations of sarcoidosis, Rheumatology, Volume 57, Issue 5, May 2018, Pages 777-783.
[11]	Henrie TR, Skedros JG. Sarcoid of the Upper Humerus Found Incidentally on MR Images Obtained for Work-Up of Rotator Cuff Tear Where Compromised Tissue Quality Was a Concern for Surgical Success. Case Rep Radiol. 2018; 2018: 3579527. Published 2018 Jun 10.
[12]	Busto U, Naranjo CA, Sellers EM. Comparison of two recently published algorithms for assessing the probability of adverse drug reactions. Br J Clin Pharmacol. 1982; 13: 223-7.
[13]	Fish, D. N., and A. T. Chow. “The Clinical Pharmacokinetics of Levofloxacin.” Clinical Pharmacokinetics 32, no. 2 (February 1997): 101-19.
[14]	Hall, Mederic M., Jonathan T. Finnoff, and Jay Smith. “Musculoskeletal Complications of Fluoroquinolones: Guidelines and Precautions for Usage in the Athletic Population.” PM&R 3, no. 2 (February 2011): 132-42.
[15]	Lozo, Edith, Kai Riecke, Rudolf Schwabe, Jürgen Vormann, and Ralf Stahlmann. “Synergistic Effect of Ofloxacin and Magnesium Deficiency on Joint Cartilage in Immature Rats.” Antimicrobial Agents and Chemotherapy 46, no. 6 (June 1, 2002): 1755-59. 2002.
[16]	Golomb BA, Koslik HJ, Redd AJ. Fluoroquinolone-induced serious, persistent, multisymptom adverse effects. BMJ Case Rep. 2015; 2015: bcr2015209821. Published 2015 Oct 5.